These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 26877167)

  • 1. Strain-dependent profile of misfolded prion protein aggregates.
    Morales R; Hu PP; Duran-Aniotz C; Moda F; Diaz-Espinoza R; Chen B; Bravo-Alegria J; Makarava N; Baskakov IV; Soto C
    Sci Rep; 2016 Feb; 6():20526. PubMed ID: 26877167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host Determinants of Prion Strain Diversity Independent of Prion Protein Genotype.
    Crowell J; Hughson A; Caughey B; Bessen RA
    J Virol; 2015 Oct; 89(20):10427-41. PubMed ID: 26246570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analyses of protease resistance and aggregation state of abnormal prion protein across the spectrum of human prions.
    Saverioni D; Notari S; Capellari S; Poggiolini I; Giese A; Kretzschmar HA; Parchi P
    J Biol Chem; 2013 Sep; 288(39):27972-85. PubMed ID: 23897825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quaternary structure of pathological prion protein as a determining factor of strain-specific prion replication dynamics.
    Laferrière F; Tixador P; Moudjou M; Chapuis J; Sibille P; Herzog L; Reine F; Jaumain E; Laude H; Rezaei H; Béringue V
    PLoS Pathog; 2013; 9(10):e1003702. PubMed ID: 24130496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sc237 hamster PrPSc and Sc237-derived mouse PrPSc generated by interspecies in vitro amplification exhibit distinct pathological and biochemical properties in tga20 transgenic mice.
    Yoshioka M; Imamura M; Okada H; Shimozaki N; Murayama Y; Yokoyama T; Mohri S
    Microbiol Immunol; 2011 May; 55(5):331-40. PubMed ID: 21362027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Prion Replication in the Strain-dependent Brain Regional Distribution of Prions.
    Hu PP; Morales R; Duran-Aniotz C; Moreno-Gonzalez I; Khan U; Soto C
    J Biol Chem; 2016 Jun; 291(24):12880-12887. PubMed ID: 27056328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eight prion strains have PrP(Sc) molecules with different conformations.
    Safar J; Wille H; Itri V; Groth D; Serban H; Torchia M; Cohen FE; Prusiner SB
    Nat Med; 1998 Oct; 4(10):1157-65. PubMed ID: 9771749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Conformational Stability of Abnormal Prion Protein Aggregates across the Spectrum of Creutzfeldt-Jakob Disease Prions.
    Cescatti M; Saverioni D; Capellari S; Tagliavini F; Kitamoto T; Ironside J; Giese A; Parchi P
    J Virol; 2016 Jul; 90(14):6244-6254. PubMed ID: 27122583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Size and Stability of Infectious Prion Aggregates Fluctuate Dynamically during Cellular Uptake and Disaggregation.
    Shoup D; Priola SA
    Biochemistry; 2021 Feb; 60(5):398-411. PubMed ID: 33497187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptation and selection of prion protein strain conformations following interspecies transmission of transmissible mink encephalopathy.
    Bartz JC; Bessen RA; McKenzie D; Marsh RF; Aiken JM
    J Virol; 2000 Jun; 74(12):5542-7. PubMed ID: 10823860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breakage of PrP aggregates is essential for efficient autocatalytic propagation of misfolded prion protein.
    Piening N; Weber P; Giese A; Kretzschmar H
    Biochem Biophys Res Commun; 2005 Jan; 326(2):339-43. PubMed ID: 15582583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prion Infectivity Plateaus and Conversion to Symptomatic Disease Originate from Falling Precursor Levels and Increased Levels of Oligomeric PrPSc Species.
    Mays CE; van der Merwe J; Kim C; Haldiman T; McKenzie D; Safar JG; Westaway D
    J Virol; 2015 Dec; 89(24):12418-26. PubMed ID: 26423957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodal fluorescence microscopy of prion strain specific PrP deposits stained by thiophene-based amyloid ligands.
    Magnusson K; Simon R; Sjölander D; Sigurdson CJ; Hammarström P; Nilsson KP
    Prion; 2014; 8(4):319-29. PubMed ID: 25495506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sialylation of prion protein controls the rate of prion amplification, the cross-species barrier, the ratio of PrPSc glycoform and prion infectivity.
    Katorcha E; Makarava N; Savtchenko R; D'Azzo A; Baskakov IV
    PLoS Pathog; 2014 Sep; 10(9):e1004366. PubMed ID: 25211026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A change in the conformation of prions accompanies the emergence of a new prion strain.
    Peretz D; Williamson RA; Legname G; Matsunaga Y; Vergara J; Burton DR; DeArmond SJ; Prusiner SB; Scott MR
    Neuron; 2002 Jun; 34(6):921-32. PubMed ID: 12086640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prion formation, but not clearance, is supported by protein misfolding cyclic amplification.
    Shikiya RA; Eckland TE; Young AJ; Bartz JC
    Prion; 2014; 8(6):415-20. PubMed ID: 25482601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new method for the characterization of strain-specific conformational stability of protease-sensitive and protease-resistant PrPSc.
    Pirisinu L; Di Bari M; Marcon S; Vaccari G; D'Agostino C; Fazzi P; Esposito E; Galeno R; Langeveld J; Agrimi U; Nonno R
    PLoS One; 2010 Sep; 5(9):e12723. PubMed ID: 20856860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of strain-specific PrP(Sc) elongation rates revealed a transformation of PrP(Sc) properties during protein misfolding cyclic amplification.
    Gonzalez-Montalban N; Baskakov IV
    PLoS One; 2012; 7(7):e41210. PubMed ID: 22815972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reconstitution of prion infectivity from solubilized protease-resistant PrP and nonprotein components of prion rods.
    Shaked GM; Meiner Z; Avraham I; Taraboulos A; Gabizon R
    J Biol Chem; 2001 Apr; 276(17):14324-8. PubMed ID: 11152454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.